GIVAUDAN SA NA SF 10/ CH0010645932 /
- - | Diferencia - | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | 0 Volumen de negocios: 0.00 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 41.6 mil millonesEUR | - | - |
Newsfile Corp
11:30
Research from Hellotickets Reveals the Best and Worst Travel Destinations in Europe for Hayfever Suf...
GlobeNewswire
9:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página